SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-003534
Filing Date
2020-03-06
Accepted
2020-03-06 17:17:26
Documents
73
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10k.htm 10-K 1896657
2 ex23-1.htm EX-23.1 4055
3 ex31-1.htm EX-31.1 23199
4 ex32-1.htm EX-32.1 9283
  Complete submission text file 0001493152-20-003534.txt   5342224

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pcsa-20191231.xml EX-101.INS 552649
6 XBRL SCHEMA FILE pcsa-20191231.xsd EX-101.SCH 65738
7 XBRL CALCULATION FILE pcsa-20191231_cal.xml EX-101.CAL 67363
8 XBRL DEFINITION FILE pcsa-20191231_def.xml EX-101.DEF 212691
9 XBRL LABEL FILE pcsa-20191231_lab.xml EX-101.LAB 426660
10 XBRL PRESENTATION FILE pcsa-20191231_pre.xml EX-101.PRE 323489
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-184948 | Film No.: 20695808
SIC: 2834 Pharmaceutical Preparations